The Latest Breaking News from Pascal Soriot

Pascal Soriot, chief executive of AstraZeneca, denied any rift with the Government over the decision.

It seems bizarre that ministers and UK’s largest company cannot complete investment in vital life sciences sector

Consumers started their Christmas shopping early, Kantar says; UK jobless rate rises to 4.3% while wage growth excluding bonuses is at a two-year low

Cracks are appearing in the labour market after the unemployment rate today rose to 4.3%.

A new generation of radiotherapies are redefining cancer care, offering the potential for a more powerful treatment with fewer side effects. It could become a mainstream therapy for the big "traditional" cancers that make the disease the leading cause of death worldwide, which is why Morgan Stanley forecast the radiopharma…

Editorial: The latest High Pay Centre report confirms the persistent and damaging culture of entitlement at the top of business

AstraZeneca’s Pascal Soriot and Rolls Royce’s Tufan Erginbilgic were among the highest-paid FTSE 100 CEOs, but what they make still trails behind the average pay of S&P 500 CEOs.

Bosses of UK’s biggest companies are now paid 120 times more than average full-time worker in some instances

The annual conference of the American Society of Clinical Oncology is always the biggest event-making cancer conference. And this year, the attention-grabber was AstraZeneca, as its lung and breast cancer drugs significantly slowed the spread of disease in two trials, potentially establishing the medicines as the new standard of care…